Top Markets
Coin of the day
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc

BiVictriX Therapeutics Plc

BVX
Hisse Senetlerindeki Sıralama #40613
BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm... BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm dedicated to pioneering innovative treatments for cancer. The company's core technology involves its distinctive Bi-Cygni therapeutics, which are engineered to precisely identify and combat specific cancer types. Their foremost development program, BVX001, is currently being advanced to address acute myeloid leukaemia. Established in 2016 as BiVictriX Plc, the organization officially adopted its present name, BiVictriX Therapeutics Plc, in August 2021. Its corporate headquarters are located in Macclesfield, United Kingdom.
Hisse Fiyatı
$0.13607016
Son senkronizasyon: 2024-09-10
Piyasa Değeri
$112.29K
Değişim (1 gün)
22.46%
Değişim (1 yıl)
0.00%
Ülke
GB
Ticaret BiVictriX Therapeutics Plc (BVX)

Kategori

BiVictriX Therapeutics Plc (BVX) için temettü verimi geçmişi
BiVictriX Therapeutics Plc (hisse sembolü: BVX) temettü verimi (TTM) 2026 itibariyle: 0
Son 5 yılın ortalama temettü verimi: 0.00%
BiVictriX Therapeutics Plc (BVX) için 2026 - 2026 arası temettü verimi geçmişi
Her yılın sonunda temettü verimi (TTM)
Yıl Temettü Verimi Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakiplerin temettü verimi (TTM)